Medicare Enrolled

Dr. Yucheng Liao, MD PHD

Neurology · Oxnard, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1700 N ROSE AVE, Oxnard, CA 93030
8059836929
In practice since 2006 (19 years)
NPI: 1922102029 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Liao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Liao? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Liao

Dr. Yucheng Liao is a neurology specialist in Oxnard, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Liao performed 1,356 Medicare services across 820 unique beneficiaries.

Between the years covered by Open Payments, Dr. Liao received a total of $7,600 from 50 pharmaceutical and/or device companies across 369 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Liao is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 26% volume in CA $7,600 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,356
Medicare services
Top 26% in CA for neurology
820
Unique beneficiaries
$145
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~71 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
456 $101 $150
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
434 $143 $220
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
189 $87 $200
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
88 $408 $550
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
65 $217 $330
New patient office visit, complex (60-74 min) 64 $171 $300
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
30 $244 $400
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
30 $141 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,600
Total received (2018-2024)
Avg $1,086/year across 7 years
Top 26% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
369
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,270 (95.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$330 (4.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,995
2023
$1,557
2022
$1,506
2021
$1,227
2020
$329
2019
$562
2018
$423

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$277
UCB, Inc.
$201
Lilly USA, LLC
$179
PFIZER INC.
$163
Neurocrine Biosciences, Inc.
$159
Neurelis, Inc.
$123
ARGENX US, INC.
$102
CSL Behring
$96
Teva Pharmaceuticals USA, Inc.
$94
Genentech USA, Inc.
$92
SK Life Science, Inc.
$91
Celgene Corporation
$88
AstraZeneca Pharmaceuticals LP
$60
CATALYST PHARMACEUTICALS, INC.
$47
Biogen, Inc.
$40
Eisai Inc.
$36
LivaNova USA, Inc.
$25
Otsuka America Pharmaceutical, Inc.
$22
JAZZ PHARMACEUTICALS INC.
$22
ACADIA Pharmaceuticals Inc
$21
Abbott Laboratories
$21
Grifols USA, LLC
$19
Sumitomo Pharma America, Inc.
$17
Top 3 companies account for 32.9% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,075
Amgen Inc.
$538
ABBVIE INC.
$533
Lilly USA, LLC
$408
ARGENX US, INC.
$399
SK Life Science, Inc.
$357
Teva Pharmaceuticals USA, Inc.
$355
Biogen, Inc.
$303
PFIZER INC.
$279
CSL Behring
$229
Neurocrine Biosciences, Inc.
$206
AstraZeneca Pharmaceuticals LP
$185
Biohaven Pharmaceutical Holding Company Ltd.
$179
Novartis Pharmaceuticals Corporation
$171
Biohaven Pharmaceuticals, Inc.
$145
Neurelis, Inc.
$143
AbbVie Inc.
$142
Sumitomo Pharma America, Inc.
$125
Eisai Inc.
$121
Genentech USA, Inc.
$118
Celgene Corporation
$117
EISAI INC.
$113
Amneal Pharmaceuticals LLC
$108
Supernus Pharmaceuticals, Inc.
$108
Alexion Pharmaceuticals, Inc.
$99
LivaNova USA, Inc.
$98
Horizon Therapeutics plc
$94
Acorda Therapeutics, Inc
$86
Grifols USA, LLC
$83
Otsuka America Pharmaceutical, Inc.
$70
Abbott Laboratories
$67
Lundbeck LLC
$66
Takeda Pharmaceuticals U.S.A., Inc.
$63
Sunovion Pharmaceuticals Inc.
$55
CATALYST PHARMACEUTICALS, INC.
$47
ACADIA Pharmaceuticals Inc
$40
Medtronic Vascular, Inc.
$33
Allergan, Inc.
$27
IMPEL PHARMACEUTICALS INC.
$24
JAZZ PHARMACEUTICALS INC.
$22
Mitsubishi Tanabe Pharma America, Inc.
$22
Alnylam Pharmaceuticals Inc.
$21
Allergan Inc.
$20
Avanir Pharmaceuticals, Inc.
$17
Nevro Corp.
$17
Catalyst Pharmaceuticals, Inc.
$16
EMD Serono, Inc.
$15
Adamas Pharmaceuticals, Inc.
$15
GENZYME CORPORATION
$14
Impax Laboratories, Inc.
$11
Top 3 companies account for 28.2% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BRILINTA · Briviact · COMIRNATY · EMGALITY · EPIDIOLEX · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GOCOVRI · Gamunex-C · Hizentra · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · Leqembi · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · PAXLOVID · QULIPTA · REXULTI · RYTARY · Radicava · Reveal LINQ · Rystiggo · SOLIRIS · Senza · TECFIDERA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XCOPRI · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Oxnard?
Compare neurologists in the Oxnard area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
38
Per 100K population
4.5
County median income
$107,327
Nearest hospital
ST JOHNS REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Liao is a clinical cardiology specialist, with above-average Medicare volume (top 26% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Liao experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Liao performed 456 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Liao receive payments from pharmaceutical companies?
Yes. Dr. Liao received a total of $7,600 from 50 companies across 369 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Liao's costs compare to other neurologists in Oxnard?
Dr. Liao's average Medicare payment per service is $145. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Liao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →